ERBITUX 2 MG/ML INJ FL 50 ML
(Cetuximab) - Maladie rare sans désignation orpheline
Treatment of patients with squamous cell cancer of the head and neck :
- in combination with radiation therapy for locally advanced disease,
- in combination with platinum-based chemotherapy for recurrent and/or metastatic disease.